Feb 19, 2021
On January 22, 2021, ICER released its Draft Evidence Report entitled, “Belimumab and Voclosporin for Lupus Nephritis: Effectiveness and Value.” Patients Rising Now submitted comments on the draft report. Some of the concerns raised in the letter include the...
Jan 8, 2021
On November 30, 2020, ICER released its Draft Evidence Report entitled, “Treatments for Anemia in Chronic Kidney Disease: Effectiveness and Value.” Patients Rising Now submitted comments on the draft report. Some of the concerns raised in the letter include...
Dec 15, 2020
On November 12, 2020, ICER released its Draft Evidence Report entitled, “Bempedoic Acid and Inclisiran for Patients with Heterozygous Familial Hypercholesterolemia and for Secondary Prevention of ASCVD: Effectiveness and Value.” Patients Rising Now submitted comments...
Sep 23, 2020
On August 26, 2020, ICER released its Draft Evidence Report entitled, “Valoctocogene Roxaparvovec and Emicizumab for Hemophilia A.” Patients Rising Now submitted comments on the draft report raising a number of concerns about both the substance of the...
Aug 2, 2020
Patients Rising Now Comments on ICER Draft Evidence Report: “Targeted Immune Modulators for Ulcerative Colitis: Effectiveness and...
Nov 9, 2019
Patients Rising Now appreciates the opportunity to provide our comments on ICER’s October 11th Draft Evidence Report “Janus Kinase Inhibitors for Rheumatoid Arthritis.” We are also encouraged that ICER delayed the release of the draft report to revise and update its...
